The progressive neurodegenerative Multiple System Atrophy market driven by growing awareness

Multiple system atrophy (MSA) is a rare, progressive neurodegenerative disease that affects different systems of the body. MSA damages nerve cells in various regions of the brain and spinal cord leading to problems with movement, balance, and autonomic functions like digestion, bladder control, and blood pressure regulation. There is currently no cure for MSA and treatment aims to manage its symptoms.

The Multiple System Atrophy (MSA) Market is estimated to be valued at USD 148.1 Mn in 2024 and is expected to reach USD 202.3 Mn by 2031, growing at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2031.

Multiple System Atrophy market-https://www.coherentmi.com/ind....ustry-reports/multip